Business Case

Crafted a dynamic pricing model for a rare respiratory disease to evaluate channel- and account-specific pricing and contracting options

A mid-sized biotech with several in-line products sought to optimize their pricing and reimbursement strategy by tailoring contracts to the value generated for specific channels and accounts. LSC executed targeted market research to confirm therapeutic-area and class-specific considerations that would inform the gross-to-net, including impact of novelty, unmet need, and overall PBM discounting expectations. LSC worked iteratively with our client to craft a dynamic pricing model at the channel and account level, incorporating discounts and rebates across the value chain, net price by portfolio product, marketing channel and key account. Our client was able to use the model to inform their pricing and contracting strategy across the value chain for their entire portfolio of rare disease products.